EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Case Report: Delayed-onset and recurrent infectious endophthalmitis after intravitreal dexamethasone implant

Xinyue Yang, Mengfan Li, Yiwei Zhu, Xiuli Tao, Yan Cheng

Frontiers in Medicine · 07.10.2026 · 13

DOI: 10.3389/fmed.2026.1962200 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Medicine, online erschienen am 07.10.2026. Verfasst von Xinyue Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The Second Hospital of Jilin University, Changchun, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To report a rare case of delayed-onset infectious endophthalmitis occurring 33 days after an intravitreal dexamethasone implant (Ozurdex®), with recurrence 20 days after complete pars plana vitrectomy and implant removal.

Methods

Case report with clinical findings, diagnostic workup, management, and literature review.

Results

A 51-year-old male with recurrent anterior uveitis received a dexamethasone implant for refractory cystoid macular edema. Thirty-three days post-injection, he developed acute hypopyon and severe vitritis. Emergent 25-gauge pars plana vitrectomy with implant removal was performed. Aqueous humor metagenomic next-generation sequencing (mNGS) confirmed Staphylococcus epidermidis (24,904 reads; 99.96% relative abundance), with no resistance genes detected. Postoperatively, inflammation initially resolved; however, hypopyon recurred 20 days after vitrectomy. A 6-day course of intravenous vancomycin achieved complete resolution. At final follow-up, best-corrected visual acuity improved to 20/33, with no further recurrence.

Conclusion

Endophthalmitis following corticosteroid implants may present with delayed-onset and can recur even after complete surgical removal. Systemic antimicrobial therapy may play a crucial role in eradicating residual infection in such challenging cases.

Schlagwörter

Stichwörter der Autor:innen

OzurdexStaphylococcus epidermidisdelayed-onset infectiondexamethasone implantendophthalmitispostoperative recurrence

Autor:innen und Institutionen

  • Department of Ophthalmology, The Second Hospital of Jilin University, Changchun, China.

Zitieren

APA

Yang, X., Li, M., Zhu, Y., Tao, X., & Cheng, Y. (2026). Case Report: Delayed-onset and recurrent infectious endophthalmitis after intravitreal dexamethasone implant. Frontiers in Medicine, 13. https://doi.org/10.3389/fmed.2026.1962200

Vancouver

Yang X, Li M, Zhu Y, Tao X, Cheng Y. Case Report: Delayed-onset and recurrent infectious endophthalmitis after intravitreal dexamethasone implant. Frontiers in Medicine. 2026;13. doi:10.3389/fmed.2026.1962200

BibTeX
@article{Yang2026,
  author = {Yang, Xinyue and Li, Mengfan and Zhu, Yiwei and Tao, Xiuli and Cheng, Yan},
  title = {Case Report: Delayed-onset and recurrent infectious endophthalmitis after intravitreal dexamethasone implant},
  journal = {Frontiers in Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fmed.2026.1962200}
}
Kostenlos starten →